| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.096 | 0.04 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.062 | 0.04 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.12 | 0.04 |
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.05 |